|
US3009864A
(en)
|
1958-09-18 |
1961-11-21 |
Union Carbide Corp |
Process control
|
|
US3228838A
(en)
|
1959-04-23 |
1966-01-11 |
Union Carbide Corp |
Preservation of biological substances
|
|
US3009861A
(en)
|
1961-01-13 |
1961-11-21 |
Alderton Gordon |
Isolation of bacterial spores
|
|
US3608030A
(en)
|
1969-05-21 |
1971-09-21 |
Howard Tint |
Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
|
|
US4077227A
(en)
|
1976-11-12 |
1978-03-07 |
Regents Of The University Of Minnesota |
Method of freezing liquid material in which agglomeration is inhibited
|
|
US4205132A
(en)
|
1978-07-17 |
1980-05-27 |
Microlife Technics, Inc. |
Lyophilization of bacteria
|
|
FI59925C
(fi)
|
1980-01-11 |
1981-11-10 |
Esko Viljo Nurmi |
Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
|
|
US4780987A
(en)
|
1983-10-25 |
1988-11-01 |
Plant Genetics, Inc. |
Method for the preparation of hydrated, pregerminated seeds in gel capsules
|
|
US4655047A
(en)
|
1985-03-25 |
1987-04-07 |
I.Q.F. Inc. |
Process for freezing or chilling
|
|
US4839281A
(en)
|
1985-04-17 |
1989-06-13 |
New England Medical Center Hospitals, Inc. |
Lactobacillus strains and methods of selection
|
|
EP0439453B1
(en)
|
1987-10-12 |
1994-01-19 |
Exomed Australia Pty. Ltd. (ACN 051 976 446) |
Improved method for treatment of gastrointestinal disorders
|
|
US5045446A
(en)
|
1988-08-26 |
1991-09-03 |
Cryopharm Corporation |
Lyophilization of cells
|
|
WO1990001335A1
(en)
|
1988-08-02 |
1990-02-22 |
Borody Thomas J |
Treatment of gastro-intestinal disorders
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
GB2233343B
(en)
|
1989-06-30 |
1993-07-07 |
Farmos Oy |
A bacterial preparation for use in poultry
|
|
JP2961182B2
(ja)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
US5436002A
(en)
|
1991-01-29 |
1995-07-25 |
Mycogen Corporation |
Bacillus thuringiensisisolate PS201T6 toxin
|
|
RU2035186C1
(ru)
|
1992-07-09 |
1995-05-20 |
Семен Рафаилович Резник |
Профилактический биопрепарат споролакт
|
|
CA2146747C
(en)
|
1992-10-09 |
2006-12-19 |
Brian A. Naughton |
Liver reserve cells
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
US5851545A
(en)
|
1995-08-25 |
1998-12-22 |
Sandoz Ltd. |
Insecticidal matrix and process for preparation thereof
|
|
DE69635496T2
(de)
|
1995-09-15 |
2006-07-27 |
Gerding, Dale N., Chicago |
Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
|
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
|
AUPO430496A0
(en)
|
1996-12-19 |
1997-01-23 |
Arnott's Biscuits Limited |
Prebiotics and probiotics
|
|
US5965128A
(en)
|
1997-08-13 |
1999-10-12 |
University Of Georgia Research Foundation Inc. |
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
|
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
MXPA02000504A
(es)
|
1999-07-12 |
2004-05-21 |
Clewer Ltd Oy |
Metodo de purificar agua, bacterias adecuadas para el metodo y uso de las mismas.
|
|
US6589771B1
(en)
|
1999-10-28 |
2003-07-08 |
Immunom Technologies, Inc. |
Methods for arousing dormant bacteria
|
|
US20030118547A1
(en)
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
US6613549B2
(en)
|
2000-02-10 |
2003-09-02 |
Urex Biotech, Inc. |
Probiotic therapy for newborns
|
|
AU2002221004B2
(en)
|
2000-11-30 |
2007-01-25 |
The Bio Balance Corp. |
Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
KR100437497B1
(ko)
|
2001-03-07 |
2004-06-25 |
주식회사 프로바이오닉 |
로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
|
|
MXPA03009877A
(es)
|
2001-05-04 |
2005-07-15 |
Univ Florida |
Clonacion y secuenciamiento de genes de piruvato decarboxilasa (pdc) a partir de bacterias y usos de los mismos.
|
|
ITMI20011632A1
(it)
|
2001-07-27 |
2003-01-27 |
Sanofi Synthelabo |
Composizione solida contenente spore di batteri non patogeni del genere bacillus
|
|
GB0130789D0
(en)
|
2001-12-21 |
2002-02-06 |
King S College London |
Application of spores
|
|
US8383342B2
(en)
|
2002-04-24 |
2013-02-26 |
The University Of North Carolina At Greensboro |
Compositions, products, methods and systems to monitor water and other ecosystems
|
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
|
AU2002951692A0
(en)
|
2002-09-23 |
2002-10-17 |
Vital Biotech (Hong Kong) Limited |
Improvements in or relating to vaccines
|
|
US20050180962A1
(en)
|
2003-01-30 |
2005-08-18 |
Eyal Raz |
Inactivated probiotic bacteria and methods of use thereof
|
|
CA2559596A1
(en)
|
2003-03-13 |
2004-11-25 |
Universite De Moncton (Bureau De Soutien A L'innovation) |
Antioxidant producing bacterium and uses thereof
|
|
EP1631312B1
(en)
|
2003-04-23 |
2008-09-10 |
Medarex, Inc. |
Compositions and methods for the therapy of inflammatory bowel disease
|
|
US20060046246A1
(en)
|
2003-04-24 |
2006-03-02 |
Qiandong Zeng |
Genus, group, species and/or strain specific 16S rDNA sequences
|
|
WO2004104175A2
(en)
|
2003-05-14 |
2004-12-02 |
University Of Georgia Research Foundation, Inc. |
Probiotic bacteria and methods
|
|
US20050271643A1
(en)
|
2003-08-14 |
2005-12-08 |
Iryna Sorokulova |
Bacterial strains, compositions including same and probiotic use thereof
|
|
MXPA06001821A
(es)
|
2003-08-18 |
2006-05-31 |
Bio Balance Corp |
Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma.
|
|
US20050048515A1
(en)
|
2003-08-29 |
2005-03-03 |
Garner Bryan E. |
Methods for detecting and quantifying specific probiotic microorganisms in animal feed
|
|
US7731976B2
(en)
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
WO2005074706A1
(en)
|
2004-02-03 |
2005-08-18 |
Universite De Montreal |
Use of live bacteria for growth promotion in animals
|
|
US7632520B2
(en)
|
2004-02-16 |
2009-12-15 |
Sanjeev Khandelwal |
Synergistic antibacterial formulation and to a method of making the same
|
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
|
CA2586299C
(en)
|
2004-11-01 |
2014-10-28 |
James W. Stave |
Method for detecting or enriching a target microorganism upon lysis of non-target bacteria with bacteriophage
|
|
EP2280085A3
(en)
|
2004-11-01 |
2011-02-23 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
US20060188523A1
(en)
|
2005-01-10 |
2006-08-24 |
Zhiheng Pei |
Methods for diagnosing and treating chronic tonsillitis
|
|
US7627437B2
(en)
|
2005-01-14 |
2009-12-01 |
Idaho Research Foundation |
Categorization of microbial communities
|
|
EP1869200B1
(en)
|
2005-03-25 |
2008-09-03 |
Universiteit Gent |
Enzymatic demethylation of flavonoids
|
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
|
BRPI0611492B1
(pt)
|
2005-05-31 |
2021-10-13 |
Mars, Incorporated |
Bifidobactéria probiótica felina
|
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
JP5363811B2
(ja)
|
2005-09-28 |
2013-12-11 |
ノルディスク リバランス アクティーゼルスカブ |
治療エフェクターとしてプロバイオティック細菌と発酵穀物を用いるｉｂｄ及びｉｂｓの治療
|
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
WO2007136553A2
(en)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Bacterial strains, compositions including same and probiotic use thereof
|
|
US20090324638A1
(en)
|
2006-06-12 |
2009-12-31 |
Biopeptides Corp. |
Live bacterial vaccine
|
|
JP5019563B2
(ja)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
腸内細菌賦活剤
|
|
CN101472639A
(zh)
|
2006-06-20 |
2009-07-01 |
皇家飞利浦电子股份有限公司 |
用于治疗胃肠疾病的电子胶囊
|
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
|
EE05459B1
(et)
|
2006-12-08 |
2011-08-15 |
Tartu �likool |
Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
|
|
WO2008076696A2
(en)
|
2006-12-18 |
2008-06-26 |
Washington University In St. Louis |
The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
|
CA2699550C
(en)
|
2007-09-12 |
2020-08-18 |
Targanta Therapeutics Corp. |
Method of inhibiting clostridium difficile by administration of oritavancin
|
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
|
US8236508B2
(en)
|
2008-01-29 |
2012-08-07 |
Drexel University |
Detecting and measuring live pathogens utilizing a mass detection device
|
|
US8021654B2
(en)
|
2008-03-14 |
2011-09-20 |
Danisco A/S |
Methods of treating pigs with Bacillus strains
|
|
CA2720292A1
(en)
|
2008-04-01 |
2009-10-08 |
Metametrix Clinical Laboratory |
Process and method for monitoring gastrointestinal microbiota
|
|
CN101264107A
(zh)
|
2008-05-09 |
2008-09-17 |
东北制药集团公司沈阳第一制药厂 |
地衣芽孢杆菌药物组合物及其制剂
|
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
|
JP2011528117A
(ja)
|
2008-07-15 |
2011-11-10 |
メタノミクス ヘルス ゲーエムベーハー |
胃バイパス及びそれに関連する状態を診断する手段及び方法
|
|
JPWO2010024251A1
(ja)
|
2008-08-26 |
2012-01-26 |
オリンパス株式会社 |
糞便試料の調製方法、糞便試料調製用溶液、及び採便用キット
|
|
WO2010030997A1
(en)
|
2008-09-12 |
2010-03-18 |
The Washington University |
Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss
|
|
WO2010036876A2
(en)
|
2008-09-25 |
2010-04-01 |
New York University |
Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
|
|
AU2009320350B2
(en)
|
2008-11-03 |
2015-09-24 |
Tufts University |
Methods and compositions for inhibiting Clostridium difficile spore germination and outgrowth
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
IT1392672B1
(it)
|
2009-01-12 |
2012-03-16 |
Wyeth Consumer Healthcare S P A |
Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
|
|
IT1393931B1
(it)
|
2009-02-25 |
2012-05-17 |
Neuroscienze Pharmaness S C A R L |
Composizione di spore di batteri non patogeni
|
|
EP2421984A1
(en)
|
2009-04-20 |
2012-02-29 |
Qteros, Inc. |
Compositions and methods for fermentation of biomass
|
|
EP2432484A1
(en)
|
2009-04-30 |
2012-03-28 |
Compagnie Gervais Danone |
Use of collinsella aerofaciens for reducing bloating
|
|
KR20120015335A
(ko)
|
2009-05-01 |
2012-02-21 |
마이크로파마 리미티드 |
퇴행성 질환의 예방 및 치료를 위한 박테리아 조성물
|
|
JP2010280640A
(ja)
|
2009-06-08 |
2010-12-16 |
Kirin Holdings Co Ltd |
穀類植物種子由来の不溶性食物繊維を含有する大腸癌予防用物質
|
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
|
WO2011046614A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
|
WO2010151842A2
(en)
|
2009-06-26 |
2010-12-29 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
ES2518490T3
(es)
|
2009-08-18 |
2014-11-05 |
Nestec S.A. |
Una composición nutritiva, la cual comprende cepas de Lactococcus y que reduce los síntomas de alergia, especialmente, en lactantes y en niños
|
|
WO2011022542A2
(en)
|
2009-08-19 |
2011-02-24 |
Puretech Ventures, Llc |
Administration of factors normally present in a microbial niche to improve health
|
|
WO2011022660A1
(en)
|
2009-08-21 |
2011-02-24 |
Puretech Ventures, Llc |
Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
PL2480255T3
(pl)
|
2009-09-23 |
2018-07-31 |
Thomas Julius Borody |
Terapia przewlekłych zakażeń jelitowych
|
|
WO2011043654A1
(en)
|
2009-10-05 |
2011-04-14 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
US20120276149A1
(en)
|
2009-10-15 |
2012-11-01 |
Dan Littman |
Methods for modulating bacterial infection
|
|
PH12012500687A1
(en)
|
2009-11-12 |
2012-10-29 |
Nestec Sa |
Nutritional composition for promoting gut microbiota balance and health
|
|
CA2785658C
(en)
|
2009-12-31 |
2017-10-24 |
Ira Milton Trachtman |
Compositions and method for treatment and prophylaxis of inflammatory bowel disease
|
|
US9492487B2
(en)
|
2010-02-01 |
2016-11-15 |
Matthew Ryan Garner |
Microbial product containing multiple microorganisms
|
|
FI4032586T3
(fi)
|
2010-02-01 |
2025-11-25 |
Ferring Microbiome Inc |
Bakteeriterapia clostridium difficile -koliittiin
|
|
US20130230498A1
(en)
|
2010-02-16 |
2013-09-05 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
|
|
EP2542690A2
(en)
|
2010-03-01 |
2013-01-09 |
Institut National de la Recherche Agronomique |
Method of diagnostic of inflammatory bowel diseases
|
|
AU2011223002B2
(en)
|
2010-03-01 |
2015-07-02 |
Institut National De La Recherche Agronomique |
Method of diagnostic of obesity
|
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
|
WO2011113801A1
(en)
|
2010-03-16 |
2011-09-22 |
Universiteit Gent |
Use of clostridium perfringens strain 23 to protect against necrotic enteritis
|
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
EP2591114B1
(en)
|
2010-07-06 |
2016-06-08 |
GlaxoSmithKline Biologicals SA |
Immunisation of large mammals with low doses of rna
|
|
WO2012009712A2
(en)
|
2010-07-16 |
2012-01-19 |
The Board Of Trustees Of The University Of Arkansas |
Methods and compositions including spore-forming bacteria for increasing the health of animals
|
|
FI20105825A7
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
|
US8980279B2
(en)
|
2010-07-26 |
2015-03-17 |
Qu Biologics |
Personalized site-specific immunomodulation
|
|
BR112013002667B1
(pt)
|
2010-08-04 |
2020-02-04 |
Thomas Julius Borody |
composições para transplante da flora intestinal e métodos para fazê-las e usá-las e dispositivos para administrá-las
|
|
US9386793B2
(en)
|
2010-08-20 |
2016-07-12 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
US20130224164A1
(en)
|
2010-09-10 |
2013-08-29 |
Viropharma Incorporated |
Environmental Clostridial Bacteriotherapy and Related Formulations and Methods of Manufacture and Use
|
|
US20130259899A1
(en)
|
2010-10-04 |
2013-10-03 |
Allen-Vercoe, Emma Molecular And Cellular Biology University Of Guelph |
Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
|
|
US8802099B2
(en)
|
2010-11-10 |
2014-08-12 |
National Jewish Health |
Methods to treat allergic conditions
|
|
US20120064592A1
(en)
|
2011-01-26 |
2012-03-15 |
Qteros, Inc. |
Biocatalysts synthesizing deregulated cellulases
|
|
US8927252B2
(en)
|
2011-02-09 |
2015-01-06 |
Lavivo Ab |
Synbiotic compositions for restoration and reconstitution of gut microbiota
|
|
US8511540B2
(en)
|
2011-02-18 |
2013-08-20 |
Echostar Technologies L.L.C. |
Matrix code for use in verification of data card swap
|
|
AR085409A1
(es)
|
2011-02-25 |
2013-10-02 |
Tricorder Diagnostics Llc |
Firmas microbianas como indicadores de exposicon a radiacion
|
|
EP3610881A1
(en)
|
2011-03-09 |
2020-02-19 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
US20120276056A1
(en)
|
2011-04-26 |
2012-11-01 |
Wieslaw Janusz Bochenek |
Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
|
|
US20120278201A1
(en)
|
2011-04-26 |
2012-11-01 |
Dwolla Corp. |
Location transaction processing system
|
|
WO2012159023A2
(en)
|
2011-05-19 |
2012-11-22 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
|
US9579353B2
(en)
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
|
WO2013008102A2
(en)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Methods and compositions for evaluating and/or treating chronic immune diseases
|
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
|
CA2843388A1
(en)
|
2011-07-27 |
2013-01-31 |
Max International, Llc |
Compositions comprising sugar-cysteine products
|
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
|
JP6116568B2
(ja)
|
2011-08-30 |
2017-04-19 |
アカデミッシュ メディッシュ セントラム |
インスリン抵抗性を予防および／または処置する方法
|
|
CA2848762C
(en)
|
2011-09-14 |
2021-07-27 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
|
WO2013066369A2
(en)
|
2011-10-03 |
2013-05-10 |
The Regents Of The University Of Michigan |
Methods for detecting graft-versus-host disease
|
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
AU2012322979B2
(en)
|
2011-10-11 |
2017-02-02 |
Achim Biotherapeutics Ab |
Composition comprising anaerobically cultivated human intestinal microbiota
|
|
EP3569690B1
(en)
|
2011-12-01 |
2024-08-28 |
The University of Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
GB201201766D0
(en)
|
2012-02-01 |
2012-03-14 |
Imp Innovations Ltd |
Method
|
|
WO2013121573A1
(ja)
|
2012-02-17 |
2013-08-22 |
住友商事株式会社 |
ソフトバイオマスの分解方法
|
|
WO2013166031A1
(en)
|
2012-04-30 |
2013-11-07 |
The Washington University |
Method of isolating and characterizing microorganisms that are targets of host immune responses
|
|
EP3686284A1
(en)
|
2012-05-18 |
2020-07-29 |
Genome Research Limited |
Methods and groups
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
AU2013266069B2
(en)
|
2012-05-25 |
2018-03-15 |
Sloan Kettering Institute For Cancer Research |
Methods for treating GI syndrome and graft versus host disease
|
|
EP2684469A1
(en)
|
2012-07-13 |
2014-01-15 |
Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO |
Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
CN104955466A
(zh)
|
2012-11-23 |
2015-09-30 |
赛里斯治疗公司 |
协同细菌组合物和其制造方法和用途
|
|
WO2014088982A1
(en)
|
2012-12-07 |
2014-06-12 |
Albert Einstein College Of Medicine Of Yeshiva University |
Gut barrier dysfunction treatment and prevention
|
|
KR102222273B1
(ko)
|
2013-02-04 |
2021-03-08 |
세레스 테라퓨틱스, 인코포레이티드 |
조성물 및 방법
|
|
WO2014121304A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods
|
|
HK1220495A1
(zh)
|
2013-03-14 |
2017-05-05 |
Seres Therapeutics, Inc. |
从材料和组合物中检测和富集病原体的方法
|
|
WO2014145958A2
(en)
*
|
2013-03-15 |
2014-09-18 |
Seres Health, Inc. |
Network-based microbial compositions and methods
|
|
JP2016520305A
(ja)
|
2013-05-03 |
2016-07-14 |
ネステク ソシエテ アノニム |
消化管微生物叢中のラクノスピラ科細菌及び体重との関連性
|
|
WO2015018307A1
(en)
|
2013-08-06 |
2015-02-12 |
Bgi Shenzhen Co., Limited |
Biomarkers for colorectal cancer
|
|
EP3074027B1
(en)
|
2013-11-25 |
2024-12-18 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
EP3082431A4
(en)
|
2013-12-16 |
2017-11-15 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
WO2015179437A1
(en)
|
2014-05-19 |
2015-11-26 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for reducing clostridium difficile infection
|
|
DK3223835T3
(en)
|
2014-11-25 |
2025-02-17 |
Memorial Sloan Kettering Cancer Center |
Intestinal microbiota and gvhd
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
WO2017008026A1
(en)
*
|
2015-07-08 |
2017-01-12 |
Seres Therapeutics, Inc. |
Methods of treating colitis
|
|
US10300043B2
(en)
|
2015-08-12 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof
|
|
CA2997100A1
(en)
|
2015-09-04 |
2017-03-09 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for detecting risk of cancer relapse
|
|
WO2017074257A1
(en)
|
2015-10-26 |
2017-05-04 |
Nanyang Technological University |
Non-viable derivatives of clostridium sporogenes as anti-cancer therapeutic agents
|
|
EP4233884A3
(en)
|
2015-11-24 |
2023-10-04 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
|
CA3006105A1
(en)
|
2015-11-25 |
2017-06-01 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization
|
|
KR20180094950A
(ko)
|
2015-12-14 |
2018-08-24 |
메타보겐 에이비 |
간내 담즙정체증 및 관련 간 질환들의 치료
|
|
AU2017234120B2
(en)
|
2016-03-14 |
2024-06-20 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
WO2017160944A2
(en)
|
2016-03-15 |
2017-09-21 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and preventing graft versus host disease
|
|
ES2987655T7
(en)
|
2016-04-19 |
2025-04-29 |
Genome Res Ltd |
Bacteriotherapy
|
|
US9999641B2
(en)
*
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
|
PT3468573T
(pt)
|
2016-06-14 |
2023-10-16 |
Vedanta Biosciences Inc |
Tratamento de uma infeção por clostridium difficile
|
|
EP3518946A4
(en)
|
2016-09-27 |
2020-09-09 |
Board of Regents, The University of Texas System |
METHODS TO IMPROVE IMMUNE CHECKPOINT BLOCKING TREATMENT BY MODULATING THE MICROBIOME
|
|
BR112020002992A2
(pt)
|
2017-08-14 |
2020-08-18 |
Seres Therapeutics, Inc. |
composições e métodos para tratamento de doença colestática
|
|
CN111432825A
(zh)
|
2017-10-03 |
2020-07-17 |
赛里斯治疗公司 |
色胺代谢的操纵
|
|
CA3080586A1
(en)
|
2017-10-30 |
2019-05-09 |
Seres Therapeutics, Inc. |
Compositions and methods for treating antibiotic resistance
|
|
JP2021511827A
(ja)
|
2018-01-23 |
2021-05-13 |
ザ ジェネラル ホスピタル コーポレイション |
ミトコンドリア機能を向上させる組成物および方法
|
|
CA3095356A1
(en)
|
2018-03-28 |
2019-10-03 |
Seres Therapeutics, Inc. |
Microbiome compositions for treatment of cancer
|
|
WO2019191694A1
(en)
|
2018-03-29 |
2019-10-03 |
Seres Therapeutics, Inc. |
Compositions and methods for treating inflammatory bowel diseases
|
|
US20210196766A1
(en)
|
2018-05-24 |
2021-07-01 |
Seres Therapeutics, Inc. |
Designed bacterial compositions and uses thereof
|
|
US20220017853A1
(en)
|
2018-12-05 |
2022-01-20 |
Seres Therapeutics, Inc. |
Compositions for stabilizing bacteria and uses thereof
|
|
BR112022010411A2
(pt)
|
2019-11-27 |
2022-08-23 |
Seres Therapeutics Inc |
Composições bacterianas projetadas e usos das mesmas
|